The keynote speaker could be considered the main attraction, the headliner, or the star of an event. A keynote speech serves as a powerful tool for setting the tone and capturing the attention of an audience. It is designed to convey a central message or idea that can inspire, motivate, or inform the listeners. The purpose of a keynote speech is to spark curiosity, stimulate discussion, and create a lasting impact on the audience. Keynote presentations are typically given by distinguished speakers who are experts in their field or have significant influence or expertise in the topic being discussed. With the power to influence, energize, ignite, and even empower an audience, an impactful keynote speech has the potential to make or break an event’s success.
We are excited to announce that keynote presentation by distinguished and reputed highly affiliated keynote speaker's, "Dr Lembit Rägo" and "Dr. Philippe Lechat".
Keynote Speaker Bio: "Dr Lembit Rägo is affiliated World Health Organization (WHO) Headquarters, Geneva, as Coordinator of Quality Assurance and Safety: Medicines (QSM) team which included activities related to International Nonproprietary Names (INNs), Quality Assurance, Pharmacovigilance, Regulatory Support, Fighting Falsified Medicines and Prequalification of Medicines. During 2000/2001 Dr Rägo laid the foundations for the World Health Organization (WHO) Prequalification of Medicines Programme and has continued to contribute to its development ever since. From 2002, he was the main organizer of WHO biennial International Conference of Drug Regulatory Authorities (ICDRA) bringing together regulators from around 100 countries all over the World. From September 2013, Dr Rägo served as the Head of WHO’s Regulation of Medicines and Other Health Technologies unit.
He is well known to many senior regulators in all parts of the World, frequent speaker in different international fora and has numerous publications including on several aspects of regulatory affairs."
Speech Title: Real World Data and Real World Evidence in Regulatory Decision Making
Keynote Speaker Bio: "Dr. Philippe Lechat" is Emeritus Professor of Paris-Cité University, France, Chairman of The Drug Committee of Assistance Publique of Paris Hospitals, Head of Drug Evaluation Department In The French Regulatory Agency, Had Published more than 250 Scientific Publications, Head of Pharmacology Department, Pitiè-Salpêtrière Hospital In Paris. With a wealth of experience in Pharmaceutical research, he brings a unique perspective that will undoubtedly enrich our conference."
Speech Title: Exposure Ratio Between Generic And Reference Drugs During Bioequivalence Studies
The keynote presentation promises to be an engaging and thought-provoking experience for all attendees.